미국의 CT 및 MRI 조영제 시장 규모, 점유율, 동향 분석 보고서 : 모달리티별, 제품별, 용도별, 투여 경로별, 최종 용도별, 부문 예측(2025-2030년)

U.S. CT and MRI Contrast Media Market Growth & Trends:

The U.S. CT and MRI contrast media market size is anticipated to reach USD 3.17 billion by 2030, expanding at a CAGR of 7.23% from 2025 to 2030, based on a new report by Grand View Research, Inc. This growth can be attributed to the growing competition among the market participants, rising research activities, and the increasing number of clinical trials and studies. Moreover, the rising focus of industry players on product approvals is anticipated to propel market growth in the coming years.

For instance, in June 2023, Ultravist, an iodine-based contrast agent from Bayer, received approval from the U.S. Food and Drug Administration for contrast-enhanced mammography. Ultravist is also indicated for contrast computed tomography of the body and head to evaluate non-neoplastic and neoplastic lesions in adults and pediatric patients aged 2 years and older. Thus, increasing FDA approvals of CT and MRI contrast agents is anticipated to propel the U.S. market growth in the coming years.

Currently, multiple clinical studies are examining the efficacy and utility of contrast agents in various CT and MRI examinations used for several chronic conditions. For instance, the University of Massachusetts in Worcester sponsors a clinical trial that has enrolled 258 participants. This trial compares two macrocyclic gadolinium-based contrast agents, gadobutrol (Gadavist) and gadoterate meglumine (Dotarem), for diagnosing breast diseases. The study is expected to be completed by March 2026. In addition, Emory University has been conducting a study since July 2024 to evaluate a targeted magnetic resonance imaging contrast agent in prostate cancer patients. Positive findings from these clinical studies are anticipated to increase the demand for CT and MRI contrast media in the U.S., contributing to the U.S. market growth.

U.S. CT And MRI Contrast Media Market Report Highlights:

• Based on modality, in 2024, the x-ray/ computed tomography segment dominated the market. However, the magnetic resonance imaging (MRI) segment is anticipated to grow fastest, with a CAGR of 8.52% over the forecast period.
• On the basis of product, the iodinated contrast media segment dominated the U.S. CT and MRI contrast media market in 2024. On the other hand, the gadolinium-based contrast media segment is anticipated to grow fastest in the coming years.
• Based on application, the neurological disorders segment held the largest revenue share of around 28.23% in the market in 2024. In contrast, the cardiovascular disorders segment is expected to grow fastest, with the highest CAGR over the forecast period.
• On the basis of route of administration, the intravenous segment held the largest revenue share, around 52.96%, in the U.S. CT and MRI contrast media market in 2024. This segment is also expected to grow fastest, with the highest CAGR over the forecast period due to the availability of a wide range of products in the U.S. market.
• On the basis of the end use, the hospital segment dominated the market and accounted for a revenue share of 59.92% in 2024. This segment is also expected to grow fastest over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Modality outlook
  • 2.2.3. Application outlook
  • 2.2.4. Route of administration outlook
  • 2.2.5. End-use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. CT and MRI Contrast Media Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Increasing demand for medical imaging
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Side effects and potential complications associated with the use of CT MRI and contrast media
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Increasing number of clinical trials
    • 3.2.3.2. Rising research activities
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Product recalls
• 3.3. U.S. CT and MRI Contrast Media Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. CT and MRI Contrast Media Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
• 4.2. Product Market Share, 2024 & 2030
• 4.3. Segment Dashboard
• 4.4. U.S. CT and MRI Contrast Media Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Gadolinium-based Contrast Media
    • 4.5.1.1. Gadolinium-based contrast media market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Iodinated Contrast Media
    • 4.5.2.1. Iodinated contrast media market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. U.S. CT and MRI Contrast Media Market: Modality Estimates & Trend Analysis

• 5.1. Definitions and Scope
• 5.2. Modality Market Share, 2024 & 2030
• 5.3. Segment Dashboard
• 5.4. U.S. CT and MRI Contrast Media Market by Modality Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Magnetic Resonance Imaging
    • 5.5.1.1. Magnetic resonance imaging market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.2. Elucirem/Vueway
      • 5.5.1.2.1. Elucirem/Vueway market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.3. Dotarem
      • 5.5.1.3.1. Dotarem market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.4. ProHance
      • 5.5.1.4.1. ProHance market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.5. MultiHance
      • 5.5.1.5.1. MultiHance market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.6. Gadovist
      • 5.5.1.6.1. Gadovist market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.7. Eovist / Primovist
      • 5.5.1.7.1. Eovist / Primovist market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.8. Clariscan
      • 5.5.1.8.1. Clariscan market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.9. Other Generics
      • 5.5.1.9.1. Other generics market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. X-ray/Computed Tomography
    • 5.5.2.1. X-ray/computed tomography market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.2. Optiray
      • 5.5.2.2.1. Optiray market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.3. ISOVUE
      • 5.5.2.3.1. ISOVUE market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.4. Ultravist
      • 5.5.2.4.1. Ultravist market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.5. Omnipaque
      • 5.5.2.5.1. Omnipaque market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.6. Visipaque
      • 5.5.2.6.1. Visipaque market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.7. Other Generics
      • 5.5.2.7.1. Other generics market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. U.S. CT and MRI Contrast Media Market: Application Estimates & Trend Analysis

• 6.1. Definitions and Scope
• 6.2. Application Market Share, 2024 & 2030
• 6.3. Segment Dashboard
• 6.4. U.S. CT and MRI Contrast Media Market by Application Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Cardiovascular Disorders
    • 6.5.1.1. Cardiovascular disorders market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Neurological Disorders
    • 6.5.2.1. Neurological disorders market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Gastrointestinal Disorders
    • 6.5.3.1. Gastrointestinal disorders market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.4. Cancer
    • 6.5.4.1. Cancer market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.5. Nephrological Disorders
    • 6.5.5.1. Nephrological disorders market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.6. Musculoskeletal Disorders
    • 6.5.6.1. Musculoskeletal disorders market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.7. Others
    • 6.5.7.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. U.S. CT and MRI Contrast Media Market: Route of Administration Estimates & Trend Analysis

• 7.1. Definitions and Scope
• 7.2. Route of Administration Market Share, 2024 & 2030
• 7.3. Segment Dashboard
• 7.4. U.S. CT and MRI Contrast Media Market by Route of Administration Outlook
• 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5.1. Intravenous
    • 7.5.1.1. Intravenous contrast media market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.2. Oral Contrast Media
    • 7.5.2.1. Oral contrast media market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.3. Rectal
    • 7.5.3.1. Rectal contrast media market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. U.S. CT and MRI Contrast Media Market: End Use Estimates & Trend Analysis

• 8.1. Definitions and Scope
• 8.2. End Use Market Share, 2024 & 2030
• 8.3. Segment Dashboard
• 8.4. U.S. CT and MRI Contrast Media Market by End Use Outlook
• 8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.5.1. Hospitals
    • 8.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
  • 8.5.2. Diagnostic Imaging Centers
    • 8.5.2.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
  • 8.5.3. Others
    • 8.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
  • 9.2.1. Innovators
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2024
  • 9.3.4. Bayer
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. GE Healthcare
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Guerbet
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Bracco Diagnostics Inc
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Fresenius Kabi
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives